Register
Community
Physicians
Editors
Experts
Code of conduct
Blog
Company
About
Publications
Press
Careers
Programs
Journal Club
Targeted Topic
Clinical Trial
Tumor Board
Contact Us
Sign in
Topics:
Rheumatology
•
COVID-19
•
General Rheumatology
•
Infectious disease
How do you counsel immunosuppressed patients regarding a third Covid vaccination dose if they have had 2 doses of mRNA vaccine and either pre or post vaccine Covid infection?
Related Questions
Do you recommend routine use of Evusheld for pre-exposure prophylaxis for patients on immunosuppression?
Do you hold tocilizumab for patients who are diagnosed with Covid and are with mild to moderate symptoms or non-hospitalized?
How are you timing the third dose of the COVID-19 mRNA vaccine in patients on rituximab?
Do you use tocilizumab for the treatment of severe COVID-19 in patients who are on other biologics for rheumatic diseases, such as rituximab?
How do you approach a patient on anti-TNF with positive Quantiferon(previously negative) with negative chest x-ray and no symptoms?
Are there any benefits of immediate vs delayed (1-2 weeks) cyclophosphamide while awaiting infectious work up in the setting of severe or organ threatening manifestations of autoimmune disease?
How do you approach biologic initiation in patients with inflammatory arthritis and repeatedly indeterminate Quantiferon?
What is the difference between Multisystem Inflammatory Syndrome in Adults (MIS-A) and MAS/HLH?
Are you recommending monkeypox vaccination to immunocompromised patients at high risk?
Do you recommend re-vaccination in immunosuppressed patients who completed hepatitis B vaccine series but are found to have undetectable or low surface antibody titers?
